Breakout 3A – Management of Complications of Cirrhosis
Aug 14, 2021 4:15pm ‐ Aug 14, 2021 4:55pm
Identification: 11.7
Breakout 3B – Pancreatic Cancer: Should We Screen?
Aug 14, 2021 4:15pm ‐ Aug 14, 2021 4:55pm
Identification: 11.8
Sponsored Product Theater: CDPATH™ a Personalized Prognostic Tool for Crohn’s disease
Aug 14, 2021 5:00pm ‐ Aug 14, 2021 6:00pm
Identification: 13
Dr. Siegel discusses CDPATH, which uses a blood test to evaluate an adult patient’s potential risk within 3 years of developing bowel strictures, internal penetrating disease, or non-perianal surgery (bowel resection or stricturoplasty). Used with physician’s assessment, CDPATH can help facilitate shared decision-making (U.S. availability; no cost to eligible patients).
This Product Theater is sponsored by Takeda and is not affiliated with AGA.
